Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.100 |
None |
1.000 |
16 |
|
2000 |
2019 |
IMMUNODEFICIENCY 50
|
disease |
|
Disease or Syndrome
|
1
|
2
|
0.700 |
None |
1.000 |
3 |
2
|
2016 |
2018 |
cervical cancer metastasis
|
disease |
|
Neoplastic Process
|
35
|
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Endothelial dysfunction
|
phenotype |
|
Disease or Syndrome
|
716
|
25
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
cancer angiogenesis
|
phenotype |
|
Neoplastic Process
|
44
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
HIV-1 infection
|
disease |
|
Disease or Syndrome
|
695
|
94
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Oestrogen receptor positive breast cancer
|
disease |
|
Neoplastic Process
|
510
|
58
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
cocaine use
|
disease |
|
Mental or Behavioral Dysfunction
|
67
|
8
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Immunosuppression
|
disease |
|
Disease or Syndrome
|
632
|
9
|
0.010 |
None |
1.000 |
1 |
|
1995 |
1995 |
Feline Osteosarcoma
|
disease |
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
estrogen receptor-negative breast cancer
|
disease |
|
Neoplastic Process
|
356
|
40
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
HER2-negative breast cancer
|
disease |
|
Neoplastic Process
|
160
|
18
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
X- linked recessive
|
phenotype |
|
Finding
|
172
|
1
|
0.100 |
None |
|
0 |
|
|
|
Decreased antibody level in blood
|
phenotype |
|
Finding
|
75
|
5
|
0.100 |
None |
|
0 |
|
|
|
Apathy
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
83
|
9
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Myocarditis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
285
|
2
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Myocardial Ischemia
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
756
|
103
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Drug abuse
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
405
|
39
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Drug Dependence
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
248
|
31
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Muscular Dystrophy
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
280
|
67
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Dysferlinopathy
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
30
|
59
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Neurofibromatosis 2
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nervous System Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
127
|
49
|
0.020 |
None |
1.000 |
2 |
|
1995 |
2008 |
Huntington Disease
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
978
|
115
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Combined immunodeficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases
|
Disease or Syndrome
|
86
|
11
|
0.300 |
strong |
1.000 |
1 |
|
2018 |
2018 |
Nephrogenic Syndrome of Inappropriate Antidiuresis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
14
|
4
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |